Sanigad Hydro Limited (SGHL)
Hydropower · Rs. 499.30 18.20 (+3.78%) as of Sep 7, 2026
Price — last 6 months
Full chart →Open
481.10
High / Low
500.00 / 481.00
Prev. close
481.10
Volume
55,299
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—
MASTER score
Mechanical 0–100 technical ranking. Methodology →
Promoter holding—
Public holding—
Stock performance
1-week change
+5.96%
1-month change
-3.61%
3-month change
—
6-month change
—
YTD change
—
1-year change
—
1-month high
557.00
1-month low
465.80
From 52-week high
—
From 52-week low
—
180-day avg price
501.14
360-day avg price
501.14
Avg volume (1w)
46,061
Avg volume (1m)
70,023
Avg volume (6m)
73,301
Avg volume (12m)
73,301
Daily volatility (1m)
2.20%
Beta vs NEPSE (1y)
—
Valuation
EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—
P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →
Key indicators vs Hydropower
EPS (Rs.)
N/A
min -29.72avg 4.88max 29.72
—
P/E
N/A
min 18.94avg 105.79max 672.73
—
P/B
N/A
min 2.20avg 4.44max 32.46
—
Networth / Share (Rs.)
N/A
min -25.60avg 101.08max 210.87
—
ROE (%)
N/A
min 0.00avg 6.11max 65.79
—
Technical indicators
| RSI (14) | 52.55 | Neutral |
| MACD | -4.03 | Bearish |
| EMA 5 | 489.91 | Bullish |
| EMA 20 | 501.70 | Bearish |
| EMA 180 | — | — |
| SMA 50 | — | — |
| SMA 200 | — | — |
Pivot levels (classic)
S3
467.87S2
474.43S1
486.87PP
493.43R1
505.87R2
512.43R3
524.87Key financials — last 8 quarters
worsebetter vs same quarter last yearamounts in Rs · per-share in RsNo filed statements found.
More Hydropower stocks
SGHL — frequently asked questions
What is Sanigad Hydro Limited's share price?
Rs. 499.30 as of Sep 7, 2026, the latest NEPSE trading session (+3.78% on the day).
What dividend did SGHL pay?
No dividend on record for the most recent fiscal year in our data.
Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.